What this study is
This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.
Study details
- Sponsor
- Methodist Health System
- Conditions
- Benign or Malignant Pancreatic Diseases
- Enrolling
- 500 people
- Starts
- 2019-03-05
- Est. completion
- 2028-01-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present; Age ≥18 years
You can't join if
- Patients that are not diagnosed with or treated for pancreatic diseases; Age < 18 years
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openTrinity Surgical Consultants, Methodist Richardson Medical Center
Richardson, Texas, United States
- Dhiresh R Jeyarajah, MD · Contact972-619-3500
Recruiting
Study team
Sponsor
Methodist Health System
Study ID 036.HPB.2018.R
Principal investigator
Dhiresh Jeyarajah, M.D.
Methodist Richardson Medical Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.